Xilinx Raises Quarterly Dividend $0.03 per Diluted Share
SAN JOSE, Calif., March 13, 2012-- Xilinx, Inc. (Nasdaq: XLNX) today announced that its Board of Directors declared a quarterly cash dividend of $0.22 per outstanding share of common stock, an increase from the dividend of $0.19 per outstanding share of common stock paid in each of the immediately preceding four quarters. The quarterly dividend will be payable on June 6, 2012 to all stockholders of record at the close of business on May 16, 2012. "The increase in our quarterly dividend reflects our continued confidence in our business model as well as our commitment to returning shareholder value," said Moshe Gavrielov, Xilinx President and Chief Executive Officer.
About Xilinx
Xilinx is the world's leading provider of programmable platforms. For more information, visit www.xilinx.com.
|
Xilinx, Inc. Hot IP
Related News
- Xilinx Raises Quarterly Dividend $0.03 per Diluted Share; Reiterates Sales Guidance for March Quarter
- Xilinx Sales Up 10% Sequentially; Quarterly Dividend Increased $0.02 Per Share
- MOSAID Declares First Quarterly Dividend of $0.125 Per Share and Announces Intention to Make Normal Course Issuer Bid
- M31 earned NT$12.16 per share in 2022 and approved dividend of NT$8 in cash and NT$1 equivalent in stock
- TSMC Board of Directors Proposes NT$8 Cash Dividend per Share
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |